We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
MALVERN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for...
The pre-market scene in the United States witnessed significant movements in various stocks, reflecting investor reactions to corporate results and future outlooks. Among the highlights...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.1 | 31 | 10 | 13.6499 | 8.86 | 260794 | 10.4487784 | CS |
4 | 1.37 | 11.6794543905 | 11.73 | 13.6499 | 8.86 | 188549 | 11.07516265 | CS |
12 | 1.68 | 14.711033275 | 11.42 | 13.6499 | 8.1001 | 217264 | 10.53533011 | CS |
26 | 5.1 | 63.75 | 8 | 22.49 | 5.42 | 257491 | 11.32599892 | CS |
52 | -2.57 | -16.4007657945 | 15.67 | 22.49 | 5.42 | 146635 | 11.38137608 | CS |
156 | -10.6 | -44.7257383966 | 23.7 | 132 | 5.42 | 255121 | 44.13028384 | CS |
260 | 4.1125 | 45.7579972184 | 8.9875 | 132 | 2.418 | 260089 | 33.75651485 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions